Androderm

Quick links to important sections

Androderm

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Androderm

Property Description
Active ingredient Testosterone (INN)
Form Transdermal patch (Transdermal system)
Pharmacological class Androgen (Schedule III Controlled Substance)
Common use Androgen replacement therapy (ART)
Brand Origin Developed by Watson Pharmaceuticals (Now part of AbbVie)

What Type of Medicinal Product is Androderm?

Androderm is a prescription-only monotherapy primarily intended for adult males, with its active ingredient being Testosterone. This medication is classified as an Androgen agent and is a Schedule III Controlled Substance, placing it within the larger Hormone replacement therapy (HRT) group. As a form of Androgen replacement therapy (ART), its therapeutic function is to introduce Testosterone when there is a documented deficiency. Pharmacological studies confirm that this type of replacement is clinically recognized for supporting the development and maintenance of male secondary characteristics and functions.

Composition and Delivery: The Transdermal System

The distinctive dosage form of Androderm is a non-scrotal Transdermal patch, administered via the transdermal route. This Transdermal system is specifically designed for nightly application to non-scrotal areas, such as the back, abdomen, or upper arms. Unlike other Testosterone formulations, the patch provides continuous delivery and sustained release of the hormone, facilitating its systemic absorption. This delivery method is intended to achieve a serum testosterone concentration profile that more closely approximates the natural daily hormonal variations observed in healthy young men.

General Purpose of Androgen Replacement Therapy

The general purpose of using Androderm is to treat conditions associated with a deficiency or absence of endogenous testosterone, most commonly hypogonadism. This androgen replacement therapy aims to supplement the patient’s insufficient endogenous testosterone production to restore physiological hormonal levels. By providing a steady supply of the androgen via controlled sustained release, the therapeutic agent supports the maintenance of hormonal balance, which is the foundational goal of treating testosterone deficiency in adult males.

What side effects are possible with Androderm?

Possible Side Effects and Safety Information: Androderm

The officially documented safety profile of Androderm (testosterone transdermal system) is structured around site-specific, systemic, and population-specific safety considerations as detailed in regulatory documents.

Adverse Reactions by Classification

The most frequent adverse events are classified as Very Common or Common and involve the Skin and Subcutaneous Tissue Disorders at the application site. These reactions include pruritus (itchiness), erythema (redness), blistering, and induration. Other Common systemic effects include headache, prostatic abnormalities (such as increases in Prostate Specific Antigen (PSA)), and the potential for gynecomastia (breast enlargement).

Serious and Clinically Significant Safety Concerns

The regulatory label highlights risks of serious adverse reactions, particularly within the Cardiovascular and Hematologic systems. These include the potential for Venous Thromboembolism (VTE), which encompasses Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), as well as an increase in red blood cell mass known as Polycythemia. The label also notes the risk for the development or worsening of Sleep Apnea and the potential for edema (fluid retention) that may be complicated by congestive heart failure in individuals with pre-existing cardiac, renal, or hepatic disease.

Population-Specific Restrictions

Androderm is strictly contraindicated in women and children due to the risk of virilization in females and potential acceleration of bone maturation in children. Older adults may face an increased risk of worsening Benign Prostatic Hyperplasia (BPH) and are subject to specific safety monitoring. A formal transfer risk is also documented, warning against secondary exposure to the drug substance via contact with the application site.

Overdose and Emergency Response

Androderm Overdose and When to Seek Help

An overdose of Androderm (testosterone transdermal system) is rare when the medication is used exactly as prescribed. However, the risk of serious side effects increases with the use of higher than recommended doses, or if multiple patches are applied simultaneously. Symptoms of an overdose are primarily an exaggeration of known androgen-related side effects.

Overdose management involves immediate removal of the patches. Treatment is generally supportive, as there is no specific antidote for testosterone overdose.

Symptom Category Potential Signs of Overdose (Exaggerated Side Effects)
Cardiovascular/Neurological Sudden, severe headache; slurred speech; sudden weakness or numbness on one side of the body; blurred vision; seizures.
Hormonal/Mental Extreme irritability or aggression; severe acne; sudden or severe mood changes; prolonged, frequent, or painful erections.
Other Fluid retention leading to severe swelling of the ankles or feet; difficulty breathing; yellowing of the skin or eyes (jaundice).

When to seek help:

If you suspect an overdose, such as if a child or a woman has been accidentally exposed, or if you or another user experiences any of the severe symptoms listed above, seek emergency medical attention immediately by calling emergency services. You should also contact a poison control center for professional advice. Do not wait for symptoms to worsen. If possible, have the medication packaging available to provide to healthcare professionals.

Therapeutic Uses of Androderm

What Androderm Treats: Main Uses and Benefits

Androderm is used exclusively as a form of Androgen Replacement Therapy (ART) to address conditions in adult males associated with a confirmed absence or deficiency of naturally produced testosterone, a condition known as hypogonadism. This therapeutic approach is consistent with established standards for Testosterone Replacement Therapy, particularly for males with Primary Hypogonadism and Hypogonadotropic Hypogonadism. The treatment is focused on providing supportive and symptomatic relief by restoring hormone balance.

It is relevant for easing symptom clusters that may become intense or disruptive, including low libido, erectile difficulties, reduced muscle mass, and chronic fatigue.

Symptomatic Domains and Therapeutic Support

The medication is applied across domains where additional symptomatic support is needed. It helps address groups of symptoms that create noticeable interference with daily stability, particularly in the domain of sexual health and the maintenance of physical characteristics. The medication may assist with maintaining functional stability when symptoms interfere with routine activities.

It is commonly used to help manage associated chronic fatigue, and may assist with easing mood disturbances and supporting a sense of vitality. This supportive relief helps maintain a sense of stability when symptoms are more noticeable, supporting general well-being during symptomatic phases.


Quick Fact: Support for Chronic Fatigue Androderm is commonly used to help with chronic fatigue and low energy levels.

Eligibility and Restrictions for Use

Who Can and Cannot Use Androderm?

Androderm is strictly indicated for adult males (age 18 years and older) who have a medically confirmed deficiency or absence of endogenous testosterone (hypogonadism), specifically for Primary or Hypogonadotropic Hypogonadism. Regulatory eligibility is defined by absolute contraindications and population-specific restrictions.


Eligibility Constraints

Eligibility Domain Constraint or Exclusion Status
Oncological Contraindications Contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate.
Pregnancy and Gender Contraindicated in women who are pregnant (risk of fetal harm) and is not indicated for use in women generally.
Age Limitations Safety and efficacy are not established in males less than 18 years old or for treating “age-related hypogonadism”.
Organ Status Use requires caution and close monitoring in patients with pre-existing cardiac, renal, or hepatic disease due to the risk of fluid retention (edema/heart failure).

Official Eligibility Statements

The eligibility profile is strictly regulated. Use is limited to replacement therapy for a documented deficiency. Patients with Benign Prostatic Hyperplasia (BPH) must be monitored for worsening signs. There are insufficient long-term safety data in geriatric patients to fully assess potential risks of cardiovascular disease and prostate cancer.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Androderm (Testosterone Transdermal System) describes specific pharmacodynamic and absorption-related outcomes when co-administered with certain medications, as documented in regulatory labeling.

Documented Pharmacodynamic Interactions

Co-administration with Oral Anticoagulants requires close monitoring. Regulatory documents state that androgens may alter anticoagulant activity, which necessitates more frequent monitoring of the International Normalized Ratio (INR) and prothrombin time for patients receiving agents such as Warfarin.

Concurrent use with Corticosteroids or Adrenocorticotropic Hormone (ACTH) may enhance the risk of fluid retention (edema). This risk of fluid retention is a particular consideration for patients with pre-existing cardiac, renal, or hepatic disease.

Androgens may also affect glucose metabolism. Co-administration with Anti-diabetic Agents (including Insulin) may result in a decrease in blood glucose levels, which requires monitoring of the patient’s insulin or anti-diabetic agent requirement.

Exposure-Altering and Procedural Constraints

The physical characteristics of the transdermal patch introduce a procedural constraint related to topical application. Pre-treatment of the application site with Triamcinolone Ointment is documented to significantly reduce the systemic absorption of Testosterone from the patch. Conversely, the cream formulation of Triamcinolone did not significantly alter absorption. This distinction establishes a restriction against using the ointment formulation prior to patch application.

Mechanism of Action

Genomic and Non-Genomic Receptor Activation

Testosterone enters target cells and acts as a full agonist at the intracellular Androgen Receptor (AR). This binding initiates the primary molecular action by launching the genomic signaling pathway—the process of regulating gene transcription via binding to Androgen Response Elements (AREs)—and rapid, secondary effects via non-genomic pathways.


Enzyme-Dependent Metabolic Cascade

The diverse physiological action is regulated by necessary metabolic conversions. The enzyme 5-alpha reductase (5alpha-reductase) converts a portion of the molecule into the androgen Dihydrotestosterone (DHT), which has a higher binding affinity for the AR. Simultaneously, Aromatase converts another fraction into Estradiol (E2). This dual-enzyme cascade is required for engaging both AR and Estrogen Receptors, contributing to regulatory effects on bone mineral density.


Systemic Anabolic Pathway Modulation

A primary consequence of AR and Estrogen Receptor activation involves the modulation of systemic processes toward anabolism, driving the acceleration of protein synthesis and the inhibition of catabolic processes. This mechanistic cascade promotes protein accretion in skeletal muscle tissue and stimulates erythropoiesis (red blood cell production) within the bone marrow.

Dosage and Administration Information

How to Use Androderm

Androderm is a transdermal system (patch) applied to the skin, which delivers testosterone into the bloodstream over 24 hours. The instructions for its use are based on established clinical guidance.

Administration and Dosing

Scope Official Instructions
Route Topical (Transdermal) to clean, dry, intact, non-scrotal skin.
Starting Dose Typically, one 4 mg/day transdermal system.
Frequency Once daily (a new patch applied every 24 hours).
Timing Applied nightly or in the evening.

Application Procedure

  1. A new system must be applied immediately after opening its protective pouch.
  2. Apply the patch to a skin site on the back, abdomen, upper arms, or thighs.
  3. Press the patch firmly onto the skin to ensure the edges adhere well.
  4. The application site must be rotated daily. The same skin site should not be used again for at least 7 days.
  5. Patients should avoid showering, swimming, or washing the application area for a minimum of 3 hours after the system is applied.
  6. Used systems should be properly discarded by folding the adhesive side onto itself before placing it in the trash.

Dose Adjustment and Special Rules

The dosage is not adjusted by the patient. The prescribed dose is determined and may be adjusted by a healthcare provider based on early morning serum testosterone concentration measurements, typically taken approximately two weeks after starting therapy or changing the dose. The dose may be increased to 6 mg/day (by using a 4 mg/day and a 2 mg/day system) or decreased to 2 mg/day as guided by these lab results. Patches containing metal must be removed prior to an MRI scan to prevent skin burns.

Recent Clinical Evidence

Androderm: Recent Clinical Evidence


Evidence for Confirmed Hypogonadism

Research exploring the use of Androderm has primarily focused on adult men diagnosed with confirmed hypogonadism, a condition characterized by a documented deficiency of naturally produced testosterone. The foundation of the clinical evaluation includes short-term Randomized Controlled Trials (RCTs) against placebo, supported by Systematic Reviews and Pharmacokinetic (PK) studies. The primary purpose of this research was to examine circulating hormone levels following use of the transdermal system, monitoring whether the patch was associated with achieving and maintaining testosterone concentrations within the normal adult male range.

Core trials explored outcomes related to systemic imbalance and patient-reported experiences. Researchers examined sexual function, including measures of desire and erectile function, and measurements of lean body mass (muscle). Trials also monitored patient-reported outcomes describing perceived discomfort related to mood and fatigue/energy levels. Findings related to these physical measures varied across studies, and certain outcomes related to bone health, such as bone mineral density (BMD), were observed in some studies over periods up to 36 months.


Research Gaps and Unanswered Questions

Evidence contributes to the broader evidence landscape describing what is known—and what is still uncertain—about this transdermal system. The evidence base does not establish efficacy for the condition commonly referred to as age-related hypogonadism, which is associated with a general decline in testosterone without a specific underlying disease. Furthermore, efficacy has not been established in males under the age of 18 years. Local application site reactions (skin irritation) were observed in some studies and were associated with patient discontinuation in those research settings. Finally, there is limited information for long-term outcomes, and certainty remains low regarding potential long-term risks, as data for long-term outcomes remains insufficient.

Key Studies & References

  1. Male hypogonadism: Symptoms, causes, and treatments (MedlinePlus)

Frequently Asked Questions (FAQ)

Common questions about Androderm (FAQ)

Q: Can the patch fall off during exercise or swimming?

According to the official prescribing information, the patch is generally designed to remain in place during typical daily activities, including showering or swimming. However, strenuous exercise or excessive perspiration may cause the patch to loosen or fall off. The application process involves pressing the patch down firmly to ensure proper adherence to the skin.


Q: Is it possible for the patch to cause hair loss or acne?

Yes, official reports indicate that certain effects associated with androgens, such as acne and loss of head hair (male pattern baldness), have been reported as adverse effects. These occurrences are part of the overall safety profile documented by regulatory sources.


Q: Can I shower or bathe with the Androderm patch on?

Regulatory instructions state that patients should avoid swimming, showering, or washing the application site for a minimum of 3 hours after a new patch is applied. After that initial period, contact with water is generally permissible.


Q: Are there any common over-the-counter medicines that interact with Androderm?

Official drug interaction profiles indicate that concurrent use with corticosteroids (steroid medicines) may increase the risk of fluid retention (edema). Since testosterone can affect blood sugar, anti-diabetic agents may also require monitoring. Some non-prescription herbal products are also noted as potentially interfering with steroid metabolism.


Q: Is Androderm safe to use if I have heart problems?

Official labeling contains a warning that androgens may promote sodium and water retention in the body. In individuals with pre-existing heart, liver, or kidney conditions, the risk of fluid retention leading to a serious complication is a key factor noted in the product labeling.


Q: Is there a maximum age limit for using Androderm?

Androderm is indicated for adult males. While there is no definitive maximum age specified, regulatory documents state that clinical trial data supporting the prolonged use of the patch in geriatric males (men over 65 years old) are limited.


Q: Can I use lotions or oils on the skin where the patch is applied?

The patch should be applied to skin that is clean, dry, and intact. Regulatory information warns against applying any type of ointment or being oily in the application area, as this may interfere with how the medication is absorbed into the body.


Q: What are the official guidelines regarding regular monitoring while on Androderm?

Monitoring typically includes measurements of serum testosterone concentration at specific times after starting treatment or changing the dose. Monitoring also covers parameters like hematocrit (red blood cell count) and prostate status (PSA levels and BPH symptoms), as guided by the prescribing clinician.


Q: Does the medicine come in any form other than a skin patch?

Androderm is exclusively available as a transdermal patch. However, the active ingredient, testosterone, is a medicine that is also available in other prescription forms, such as topical gels or injections.


Q: Can other types of skin products, like sunscreens, impact the patch's adhesion?

Official consumer information advises that application sites that are oily or that perspire intensely may interfere with the patch's adhesion. Due to the potential for common topical products, such as sunscreens or cosmetics, to affect the patch’s ability to stick securely to the skin, official instructions emphasize a clean and dry application site.


Q: What happens if I forget to change my patch exactly on time?

Regulatory guidance provides instructions for missed doses, noting that the patch may be applied when remembered. However, if it is close to the time for the next scheduled application, the recommendation is to skip the missed dose and continue with the regular schedule. Extra patches are not advised for a missed dose.


Q: What should I do if the patch starts to peel off early?

Official information indicates that if the patch begins to peel off, it can be smoothed down with fingers to re-secure it. If the patch falls off completely before the next scheduled application time, product instructions advise replacing it with a new patch and continuing the regular dosing schedule.


Q: Does using this patch affect my natural testosterone production?

Yes, official documents indicate that testosterone therapy suppresses the body’s natural testosterone production. This happens through the feedback loop between the pituitary gland and the testes. Furthermore, studies indicate that large doses may also suppress spermatogenesis (sperm production).


Q: Do official documents mention anything about weight gain with Androderm?

Official adverse reaction data includes fluid retention (edema) as a potential side effect. This accumulation of fluid can lead to sudden weight gain, especially in individuals with existing heart, kidney, or liver conditions.


Q: What is the risk of a severe allergic reaction to the patch?

While less common than local skin reactions, there have been postmarketing reports of hypersensitivity reactions (allergic reactions) associated with topical testosterone products. These have included rare instances of severe reactions like anaphylactic shock.


Q: Is there a different way to use the patch if I have very sensitive skin?

Mild skin irritation at the application site is a common side effect. If the irritation persists or becomes more severe, such as blistering, this may be a sign of allergy. In such situations, consultation with a healthcare provider is noted, as discontinuation of treatment may be a necessary clinical option.


Q: Can exposure to sunlight affect the patch or the medication?

Official product information suggests caution for men who have a history of photosensitivity or have been sunburnt in the proposed application area within three weeks of starting therapy. This indicates that sunlight exposure may be a factor in potential skin reactions at the application site.


Q: Are there common foods or drinks that should be avoided with Androderm?

Official regulatory documents state that a normal diet may generally be continued unless specific instructions are received from a healthcare provider. No common foods or drinks are specifically listed as having major interactions.


Q: Does alcohol use interfere with the effectiveness of Androderm?

According to the product monograph, there are no specific data available regarding the interaction between alcohol consumption and the effectiveness or safety of the Androderm patch.


Q: Are there specific symptoms that mean I should stop using the patch immediately?

The labeling specifies that immediate medical attention is necessary if symptoms of a serious condition, such as a blood clot, heart attack, or stroke, are experienced. Examples include chest pain, sudden weakness or numbness on one side of the body, slurred speech, or pain/swelling in the leg.


Q: Can Androderm cause changes in cholesterol levels?

Official adverse reaction information indicates that this medication may cause changes in the level of cholesterol and fats (lipids) in the blood. The prescribing information indicates that a healthcare provider may monitor these levels during therapy due to this possibility.


Q: Is there a black box warning associated with Androderm in the US?

The FDA has required labeling changes for prescription testosterone products, including a warning about the risk of increased blood pressure in the prescribing information. The FDA has previously required warnings about cardiovascular risk to be included on the product labeling.


Q: Are there documented cases of overdose with the Androderm patch?

The patch is designed for controlled delivery, making an accidental overdose less likely than with other forms. However, symptoms of testosterone overdose are documented and can include signs such as blurred vision, severe headache, and inability to speak.

How should Androderm be stored and disposed of?

Storage Requirements

Androderm (testosterone transdermal system) patches must be stored at controlled room temperature, specifically 25 C (77 F), with allowable temperature excursions between 15 -30 C (59 -86 F). The patches must be protected from excessive heat, which could cause the drug reservoir to burst, and must be kept in their sealed protective pouches until immediate use. All patches must be stored out of the reach of children and pets to prevent accidental exposure to the controlled substance.


Disposal Instructions

Used Androderm patches must be disposed of carefully. Upon removal, a used patch must be immediately folded in half so that the adhesive sides stick together, and then discarded in the household trash. Damaged, unused, or expired patches should be handled according to local pharmaceutical waste regulations, typically by consulting a pharmacist for guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Androderm found in:

A-Z Index: